Vaccine Attitudes and Practices of Hospital Specialists
NCT ID: NCT03403114
Last Updated: 2021-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1851 participants
OBSERVATIONAL
2018-02-01
2019-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium
NCT01592838
Motivational Interviewing and Vaccine Hesitancy in Children
NCT03934008
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Have to be Vaccinated MenBVac®
NCT01054053
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)
NCT01621945
Impact of PACV Administration on Vaccine Hesitancy
NCT04450940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
a 15min questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Or to be a contract physician in participating institutions
Exclusion Criteria
* Attached practitioners
* Emergency physicians
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovative clinical research network in vaccinology (I-REIVAC)
UNKNOWN
Observatoire Régionale de la santé ORS-PACA
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Odile LAUNAY, Professor
Role: PRINCIPAL_INVESTIGATOR
CIC 1417 Centre d'investigation clinique
Pierre VERGER, MD
Role: STUDY_CHAIR
ORS PACA UMR 912 SESSTIM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CRC Annecy
Annecy, , France
CIC Besançon
Besançon, , France
CIC Clermont-Ferrand
Clermont-Ferrand, , France
CIC Dijon
Dijon, , France
CIC Lille
Lille, , France
CIC Limoges
Limoges, , France
Service d'Hygiène, Epidémiologie et Prévention, Groupement Hospitalier Edouard Herriot et Unité de recherche clinique ne Immunologie du centre hospitalier Lyon Sud
Lyon, , France
CIC Montpellier
Montpellier, , France
Service de maladies infectieuses Nancy
Nancy, , France
Service de maladies infectieuses Nîmes
Nîmes, , France
CIC Rennes
Rennes, , France
CIC Strasbourg
Strasbourg, , France
CIC Cochin Pasteur
Paris, Île-de-France Region, France
CIC Bichat
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NI16019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.